Maturitas publishes position statement on management of vertebral osteoporotic fracture

March 24, 2014

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) in the journal Maturitas on the topic of the management of postmenopausal women with vertebral osteoporotic fracture.

Vertebral osteoporotic fracture is an underestimated condition as only about a third of people with the disease seek medical attention. While it may cause acute back pain, the presentation may be insidious with gradual loss of height. Vertebral are associated with significant morbidity, excess mortality as well as being costly to healthcare providers. Also, once a woman has a fracture this increases her risk of further fracture. It is therefore important for healthcare professionals to detect and treat suspected fractures early.

The management of with osteoporotic vertebral should be provided by a multidisciplinary team. It includes early pain relief and mobilization, spinal support, spinal surgery and long term management of the underlying osteoporosis. Any other underlying pathology, such as cancer, should be sought and treated. Medical treatment of osteoporosis with effective agents such as , SERMS, bisphosphonates or denosumab, depending on age and concomitant medical conditions, need to be started as soon as possible. It is essential that the women are calcium and vitamin D replete.

These and other recommendations presented in EMAS' position statement are published in the article, "EMAS Position statement: The management of with vertebral osteoporotic fracture" by Ioannis K. Triantafyllopoulos, Kalliopi Lambropoulou-Adamidou, Cleopatra C. Nacopoulos, Nikolaos A. Papaioannou, Iuliana Ceausu, Herman Depypere, C. Tamer Erel, Faustino R. Pérez-López, Karin Schenck-Gustafsson, Yvonne T. van der Schouw, Tommaso Simoncini, Florence Tremollieres, Margaret Rees and Irene Lambrinoudaki.

Explore further: Kyphoplasty superior to vertebroplasty for vertebral fx

More information: DOI: 10.1016/j.maturitas.2014.03.002

Related Stories

Kyphoplasty superior to vertebroplasty for vertebral fx

August 27, 2012

(HealthDay)—For people with osteoporotic vertebral compression fractures, kyphoplasty (KP) is superior to vertebroplasty (VP) for correcting kyphosis, restoring vertebral height, and preventing leakage of bone cement, according ...

The deadly news about all osteoporotic fractures

November 27, 2013

It is well known that hip and vertebral fractures increase the risk of premature death. Until now, little has been known about the clinical impact of non-hip, non-vertebral fractures – so new Australian research showing ...

Alendronate reduces adjacent-level vertebral fractures

December 30, 2013

(HealthDay)—For females with osteoporosis, the rate of adjacent-level vertebral fractures is relatively low, with reduced odds with bisphosphonate therapy, according to a study published in the Dec. 1 issue of Spine.

Recommended for you

The 'love hormone' may quiet tinnitus

September 23, 2016

(HealthDay)—People suffering from chronic ringing in the ears—called tinnitus—may find some relief by spraying the hormone oxytocin in their nose, a small initial study by Brazilian researchers suggests.

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Arthritis drug may help with type of hair loss

September 22, 2016

(HealthDay)—For people who suffer from a condition that causes disfiguring hair loss, a drug used for rheumatoid arthritis might regrow their hair, a new, small study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.